| related words |
| unproven |
| failing |
| contractually |
| milestone |
| tm |
| vaccine |
| deadline |
| territory |
| none |
| earlier |
| assist |
| satisfactorily |
| discontinued |
| nda |
| monitoring |
| announce |
| commencement |
| biopharmaceutical |
| endpoint |
| analysis |
|
| related documents |
| 1446847--3/30/2010--IRONWOOD_PHARMACEUTICALS_INC |
| 930184--3/2/2009--VALEANT_PHARMACEUTICALS_INTERNATIONAL |
| 1022974--3/31/2009--DECODE_GENETICS_INC |
| 1273013--3/6/2008--PHARMACOPEIA_INC |
| 1012140--2/29/2008--ONYX_PHARMACEUTICALS_INC |
| 1022974--3/17/2008--DECODE_GENETICS_INC |
| 1333248--3/13/2008--CADENCE_PHARMACEUTICALS_INC |
| 1293243--3/14/2007--PRA_International |
| 1333248--3/28/2007--CADENCE_PHARMACEUTICALS_INC |
| 1101052--3/15/2006--MYOGEN_INC |
| 918112--9/13/2007--NEUROBIOLOGICAL_TECHNOLOGIES_INC_/CA/ |
| 1138812--3/14/2006--COTHERIX_INC |
| 881524--3/10/2010--VIVUS_INC |
| 1080014--2/26/2010--THERAVANCE_INC |
| 906465--3/5/2010--QCR_HOLDINGS_INC |
| 1003124--2/26/2010--PHARMACEUTICAL_PRODUCT_DEVELOPMENT_INC |
| 1175483--2/19/2010--NEWCASTLE_INVESTMENT_CORP |
| 1078723--3/31/2010--INTERNATIONAL_FUEL_TECHNOLOGY_INC |
| 1140657--3/15/2010--HUNTINGTON_PREFERRED_CAPITAL_INC |
| 1100682--2/19/2010--CHARLES_RIVER_LABORATORIES_INTERNATIONAL_INC |
|
| related topics |
| {product, candidate, development} |
| {competitive, industry, competition} |
| {financial, litigation, operation} |
| {product, liability, claim} |
| {loss, insurance, financial} |
| {cost, contract, operation} |
| {acquisition, growth, future} |
| {interest, director, officer} |
| {product, market, service} |
| {control, financial, internal} |
| {debt, indebtedness, cash} |
| {cost, operation, labor} |
| {gas, price, oil} |
| {system, service, information} |
| {personnel, key, retain} |
| {cost, regulation, environmental} |
| {tax, income, asset} |
| {operation, international, foreign} |
| {customer, product, revenue} |
| {stock, price, operating} |
|